Skip to content
thestock.space

Vasundhara Rasayans (BSE: VRL) had a P/E of 7.1× on 6 Nov 2026, below the industry P/E of 18.2×, and the shares are 40% below their 52-week high. It earns ROCE of 20% and ROE of 15%, and sales fell 2.0% a year over 3 years while net profit grew 1.2%. It has almost no debt, and its dividend yield is 1.5%. It is a small-cap company with a market cap of ₹42 Cr, ranked 66th of 76 Chemicals companies by market cap; the shares fell 17% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹142.00
Day high
₹142.00
Day low
₹130.10
Prev. close
₹142.00
Volume
548

Health check

3 good · 2 fair · 1 to check
  • ReturnsIn line

    −17.4% over a year, better than 3 of 7 peers.

  • Price tagCheaper

    P/E 7.1 vs industry 18.2.

  • GrowthSteady

    Sales −2.0%, profit +1.2% a year over 3 years.

  • ProfitabilityStrong

    ROCE 20.0% vs peer median 10.6%.

  • Balance sheetSolid

    Practically debt-free, Piotroski 6 of 9.

  • Red flags2 to check

    Quarterly sales down 8.3% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹42 Cr, #66 of 76 in its industry by size.

Defensive

Beta 0.34 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹35 Cr · profit ₹6 Cr
Market cap
₹42 Cr
Small cap
P/E
7.1
Industry 18.2
Price to book
1.02
Peers 2.62
Dividend yield
1.52%
ROE
15.1%
Peers 11.7%
ROCE
20.0%
Peers 10.6%
Debt to equity
0.04
Debt ₹1.81 Cr
EPS (TTM)
₹18.58
OPM (TTM)
17.5%
Net margin 16.7%
Sales growth
−8.3%
Latest quarter vs a year ago
Profit growth
+13.1%
Latest quarter vs a year ago
Price to sales
1.19
EV/EBITDA 6.2

Strengths and risks

Strengths

  • Return on capital employed of 20.0%.
  • Practically debt-free.
  • P/E of 7.1 against an industry P/E of 18.2.

Risks to check

  • Quarterly sales down 8.3% on a year ago.
  • 40% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Vasundhara Rasayans

Vasundhara Rasayans Limited engages in the manufacture and sale of antacids therapeutic category of active pharmaceutical ingredients (API) in India. It offers antacid API, such as aluminum hydroxide gel, magnesium hydroxide, magaldrate, magnesium trisilicate, magnesium silicate, and aluminum phosphate. The company also provides aluminum hydroxide gel with low heavy lead content for lake color; aluminum hydroxide amorphous, aluminum sulphate, and poly…

Headquarters
Hyderabad
Employees
42
Sector
Basic Materials
ISIN
INE406F01010

Price range

52 weeks

₹100.10₹220.00

Today

₹130.10₹142.00
Avg volume (3M)
1.1K
1-year return
minus 17.4%
From 52-week high
minus 40.3%

Peers · Chemicals

Capital-heavy industry columns

Company
NAVINFLUORNavin Fluorine International9,010.00plus 1.87%46,25050.842.718.7%34.3%0.2816.5%plus 46.1%
DEEPAKNTRDeepak Nitrite1,533.60minus 0.67%20,91719.722.310.8%18.0%0.27−0.5%minus 11.9%
TATACHEMTata Chemicals607.45minus 1.36%15,475–12.4−3.0%12.2%0.36−4.8%minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.1,155.30minus 0.69%14,59914.811.511.2%17.6%0.762.6%minus 22.7%
RPELRaghav Productivity Enhancers1,780.80plus 0.95%8,178116.0107.1–29.9%0.0223.5%plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals451.80minus 1.87%6,6396.35.410.4%14.8%0.01−8.8%minus 7.2%
ACIArchean Chemical Industries416.40minus 1.95%5,14151.323.27.7%20.0%0.28−9.2%minus 34.6%
VRLVasundhara Rasayans131.25minus 7.57%427.16.520.0%17.5%0.04−2.0%minus 17.4%
Median of 7 peers–−0.69%14,59935.222.310.6%18.0%0.28−0.5%−11.9%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
7.68.87.411.96.9
7.26.76.99.16.2
0.32.10.52.80.7
4.3%24.1%6.9%23.8%9.9%
0.70.90.70.70.4
0.10.10.10.10
0.10.10.10.10.1
0.82.813.30.9
26.0%26.0%26.0%25.7%26.0%
0.62.10.72.50.6
1.806.472.277.802.04

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−2.0%
Profit CAGR 3Y
+1.2%
EPS CAGR 3Y
+1.2%
ROE
15.1%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
37.9373435.7
–minus 2.4%minus 8.2%+5.1%
32.430.629.929.8
5.66.44.15.9
14.6%17.4%12.1%16.6%
1.31.72.32.9
0.20.20.30.4
0.10.30.40.4
10.20−0.1
7.57.95.87.9
25.2%25.8%26.4%26.4%
5.65.94.25.8
–+4.8%minus 27.5%+36.3%
17.5918.4413.3618.22

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
3.23.23.23.2
23.628.832.437.7
41.94.21.8
3.73.43.35.2
34.537.343.147.9
0.92.42.52.4
0.10.10.10.1
7.710.77.95
25.824.132.640.4
34.537.343.147.9

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−6.56−5.8−1.6
1.3−1.30.52
2.2−2.91.4−3.4
−31.8−4−3
−0.1−1.8−0.4−0.3
−6.64.2−6.3−1.9
−0.3−0.6−0.6−0.6

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you